Syngene expects outsourcing boost from West
CDMOs will play a vital role in bringing CGT and mRNA technologies to market
Indian CDMOs now scout for capital-intensive projects and invest in new technologies for global orders
Can partnerships with CRDMOs boost biosimilar manufacturing
Syngene’s client Panbela announces issuance of new patent in Japan
Indian prowess collaborations propel CRAMS market
Biologics manufacturing: An opportunity to partner with CRDMOs to bring speed, mitigate risks
SARS-CoV-2 variants: A case for expanding mRNA vaccine production globally
Biopharma companies of West approach big Indian CROs & CDMOs for multi-dimensional solutions
How Syngene International’s CFO is balancing current risks with future viability
